In Vivo Clinical Trial of Porous Starch - Hydroxyapatite Composite Biomaterials for Bone Regeneration
- Conditions
- Open Fracture of Foot
- Interventions
- Device: bone void filler
- Registration Number
- NCT02910232
- Lead Sponsor
- Chiang Mai University
- Brief Summary
Biodegradable scaffold is an accepted and commercialized medical alternative choice for bone regeneration. In this project we will used our new invention, porous starch- hydroxyapatite composite, for in vivo clinical trial.
- Detailed Description
The products were prepared from medical grade Thai rice starch mixed with high purity (\>97%) hydroxyapatite powder from fresh cow bone, and already passed in vivo animal biocompatility test, then processed by freeze-drying. There were 44 volunteers from orthopedic and neurosurgical division, 4 and 40 patients, respectively.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44
- A patient who requires treatment by surgery and product implant in bone.
- Not indicate sex type
- 18-65 years
- Patients accepted participate in the study.
- Type of surgery will be treat for only bone.
- Refused to join the study.
- Patients have an allergic history of carbohydrates and bovine bone.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description 1 bone void filler The groups were orthopedic patients and neurosurgical patients. The samples to fill the voiding space of bone and skull same as autografts.
- Primary Outcome Measures
Name Time Method Bone voids repairing 6 months The primary outcome will be assessed from satisfactory grading by operative nurses and surgeons. Add a convenient storage, package removal, contamination risk, unused material disposal, size appropriateness, tolerability by hand, ease to cut, stability when wet, weight, and disturbance to operative field.
- Secondary Outcome Measures
Name Time Method Bone voids repairing 6 months The short and long term safety and efficacy were assessed during real time operation, such as material dislodgement. Add a during follow up time for at least 1 months such as infection and allergic reaction by X-ray follow up assessment at 1, 3 and 6 months intervals, after operations.
Trial Locations
- Locations (1)
Biomedical Materials and Ceramic Industrial Research Unit
🇹🇭Chiang Mai, Thailand